(Axios) – China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new discoveries to American companies.

The big picture: China has become a linchpin in global drug development, the result of a decade-long national strategy to develop a biopharmaceutical industry. (Read More)